Cystadane
Payments companies reported to CMS as associated with Cystadane. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Cystadane, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Cystadane
These are the largest totals companies reported as associated with Cystadane. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Donny Suh | Irvine, CA | Pediatric Ophthalmology and Strabismus Specialist | $140.91 |
| Gerard Vockley | Pittsburgh, PA | $90.51 | |
| Zeba Syed | Philadelphia, PA | Ophthalmology | $20.91 |
| Paul Grimm | Palo Alto, CA | Pediatric Nephrology | $20.91 |
| Olivia Lee | Irvine, CA | Uveitis and Ocular Inflammatory Disease | $20.91 |
| Karolinne Rocha | Charleston, SC | Ophthalmology | $20.91 |
| Paulo Borjas Mendoza | Jackson, MS | $19.26 | |
| Bethany Robinette | Gulfport, MS | Family | $19.26 |
| Michelle Tharp | Jackson, MS | Nurse Practitioner | $19.26 |
Prescribed Cystadane?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.